SCHEMBL8604113

SCHEMBL8604113

c1ccc(Cc2ccc3[nH]ccc3c2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.55
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
NPC1 O15118 1/20 0.55
CYP19A1 P11511 1/20 0.50
KDM1A O60341 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
ENPP2 Q13822 1/20 0.48
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
AHR P35869 4/20 0.47
TRPA1 O75762 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ITGB2 P05107 1/20 0.47
ICAM1 P05362 1/20 0.47
ITGAL P20701 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30030142 1.00 CYP17A1 (0.55) CYP17A1CYP11B1CYP11B2NPC1CYP19A1
SCHEMBL7504545 0.85 BACE1 (0.48) CYP17A1CYP11B1CYP11B2ENPP2AHR
SCHEMBL6099420 0.85 NPC1 (0.55) NPC1CYP19A1KDM1AMAOAMAOB
SCHEMBL9075741 0.84 AHR (0.63) CYP17A1CYP11B1CYP11B2NPC1CYP19A1
SCHEMBL13539226 0.82 NPC1 (0.45) CYP17A1CYP11B1CYP11B2NPC1CYP19A1
SCHEMBL12384488 0.82 HDAC1 (0.57) NPC1CYP19A1KDM1AMAOAMAOB
SCHEMBL16741873 0.82 ENPP2 (0.54) CYP17A1CYP11B1CYP11B2NPC1ENPP2
SCHEMBL2275779 0.81 CTNNB1 (0.52) NPC1ENPP2CTNNB1WNT3ACA1
SCHEMBL6215715 0.81 GRIN1 (0.50) CYP17A1CYP11B1CYP11B2NPC1CYP19A1
SCHEMBL1570966 0.80 KDM1A (0.47) CYP17A1CYP11B1CYP11B2NPC1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998001136-A1 FORMULATIONS OF VESICANT DRUGS AND METHODS OF USE THEREOF BAYLOR COLLEGE OF MEDICINE (US) 1998-01-15 WO disclosed
US-5637593-A MIGRAINE; HYPOTENSIVE AGENTS SMITHKLINE BEECHAM PLC (GB) 1997-06-10 US disclosed
EP-0758320-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS Allelix Biopharmaceuticals Inc. (CA) 1997-02-19 EP disclosed
US-5504101-A TRYPTAMINE ANALOGS ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1996-04-02 US disclosed
WO-1995030655-A1 TRYPTAMINE DERIVATIVES AS 5-HT-1D RECEPTOR LIGANDS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1995-11-16 WO disclosed
EP-0674619-A1 TRYPTAMINE ANALOGUES AS 5-HT 1?-LIKE AGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-10-04 EP disclosed
WO-1994014770-A1 TRYPTAMINE ANALOGUES AS 5-HT1-LIKE AGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-07-07 WO disclosed